πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 175 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10646550

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10563183

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses the

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10543237

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10533171

Oligonucleotide comprising an inosine for treating DMD

BIOMARIN TECHNOLOGIES B.V. Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10526346

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10525068

Anti-inflammatory properties of marine lipid compositions

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10512675

Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic for

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10463718

Adeno-associated virus factor VIII vectors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10456412

Lipid extraction processes

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10428028

HDAC inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10308608

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10300113

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10301369

Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10301323

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10279015

TPP-1 formulations and methods for treating CLN2 disease

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10246707

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated mean

BIOMARIN TECHNOLOGIES B.V. Β· Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10239832

N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosyl

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10227323

Glucosylceramide synthase inhibitors for the treatment of diseases

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10227312

Glucosylceramide synthase inhibitors for the treatment of diseases

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10221408

Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using comp

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10179912

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenn

BIOMARIN TECHNOLOGIES B.V. Β· Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10117882

Anti-inflammatory properties of marine lipid compositions

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10105376

Omega-3 compositions

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10080803

Emulsified krill phospholipid compositions

AKER BIOMARINE ANTARCTIC AS Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted